Oncimmune Ltd (ONC):企業財務及び戦略的SWOT分析

◆英語タイトル:Oncimmune Ltd (ONC) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム


Oncimmune Ltd (Oncimmune) is a biotechnology company that discovers and commercializes technologies for the early detection of cancer. The company develops EarlyCDT, a platform technology for detecting early cancer that measures autoantibodies (immuno-biomarkers) in blood that form early in carcinogenesis. It also concentrates on R&D of cancer detection tests for various solid-tumour cancers that include lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancer. The company has also launched first test EarlyCDT-Lung that is an aid to risk assessment and early detection of lung cancer in high-risk individuals. Oncimmune is headquartered in Nottingham, the UK.

Oncimmune Ltd Key Recent Developments

Nov 07, 2016: Oncimmune Holdings: Final results for the year ended 31 May 2016
Oct 11, 2016: Oncimmune Holdings Announces Appointment of Carsten Schroeder as Non-Executive Director
Sep 22, 2016: Oncimmune Holdings: Maarten Brusse appointed Chief Commercial Officer Asia
Aug 17, 2016: Oncimmune Holdings Appoints Andrew Millet to the Board as Chief Financial Officer

This comprehensive SWOT profile of Oncimmune Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oncimmune Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Oncimmune Ltd – Key Information
Oncimmune Ltd – Overview
Oncimmune Ltd – Key Employees
Oncimmune Ltd – Key Employee Biographies
Oncimmune Ltd – Key Operational Heads
Oncimmune Ltd – Major Products and Services
Oncimmune Ltd – History
Oncimmune Ltd – Company Statement
Oncimmune Ltd – Locations And Subsidiaries
Oncimmune Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Oncimmune Ltd – Business Description
Oncimmune Ltd – Corporate Strategy
Oncimmune Ltd – SWOT Analysis
SWOT Analysis – Overview
Oncimmune Ltd – Strengths
Oncimmune Ltd – Weaknesses
Oncimmune Ltd – Opportunities
Oncimmune Ltd – Threats
Oncimmune Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Oncimmune Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Oncimmune Ltd, Key Information
Oncimmune Ltd, Key Ratios
Oncimmune Ltd, Share Data
Oncimmune Ltd, Major Products and Services
Oncimmune Ltd, History
Oncimmune Ltd, Key Employees
Oncimmune Ltd, Key Employee Biographies
Oncimmune Ltd, Key Operational Heads
Oncimmune Ltd, Other Locations
Oncimmune Ltd, Subsidiaries
Oncimmune Ltd, Key Manufacturing facilities
Oncimmune Ltd, Key Competitors
Oncimmune Ltd, SWOT Analysis
Oncimmune Ltd, Ratios based on current share price
Oncimmune Ltd, Annual Ratios
Oncimmune Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Oncimmune Ltd, Performance Chart
Oncimmune Ltd, Ratio Charts


★リサーチレポート[ Oncimmune Ltd (ONC):企業財務及び戦略的SWOT分析(Oncimmune Ltd (ONC) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。